|
Título:
|
Sex, gender, and health biotechnology: points to consider
|
|
Autores:
|
Singh Jerome ;
Bandewar Sunita ;
Singer Peter A
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
BioMed Central, 2019-09-23T13:38:53Z
|
|
Nota general:
|
BMC International Health and Human Rights, Vol 9, Iss 1, p 15 (2009)
|
|
Idiomas:
|
|
|
Palabras clave:
|
Journals AtoZ
,
BMC International Health and Human Rights
|
|
Resumen:
|
<p>Abstract</p> <p>Background</p> <p>Reproductive technologies have been extensively debated in the literature. As well, feminist economists, environmentalists, and agriculturalists have generated substantial debate and literature on gender. However, the implications for women of health biotechnologies have received relatively less attention. Surprisingly, while gender based frameworks have been proposed in the context of public health policy, practice, health research, and epidemiological research, we could identify no systematic framework for gender analysis of health biotechnology in the developing world.</p> <p>Discussion</p> <p>We propose sex and gender considerations at five critical stages of health biotechnology research and development: priority setting; technology design; clinical trials; commercialization, and health services delivery.</p> <p>Summary</p> <p>Applying a systematic sex and gender framework to five key process stages of health biotechnology research and development could be a first step towards unlocking the opportunities of this promising science for women in the developing world.</p>
|
|
En línea:
|
oai:doaj.org/article:e1181c3307ee4988a7a1c5314dd7cdcf
|
